The genes encoding IDH1/2 and BRAF are frequently altered in low-grade glioma; the presence or absence of these alterations should be determined in all patients. Maximal safe tumor resection remains ...
The emergence of vorasidenib, the first targeted therapy for certain gliomas with IDH mutations, has ignited a wave of excitement in both patient and physician spaces. But following the approval, some ...
An AI tool using temporal learning significantly outperforms traditional methods in predicting pediatric glioma recurrence, achieving 75% to 89% accuracy. The AI model analyzes multiple brain scans ...
A. Representative images of 11 C-acetate PET, and MRI in patients with glioblastoma and IDH1-mt astrocytoma. B. SUVR of 11 C-acetate uptake correlated with the WHO 2021 classification. C. The median ...
Fractionated reirradiation is safe for recurrent high-grade glioma, with a median dose of 41.4 Gy and no critical structure injuries observed. Improved overall survival correlates with better ...
Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain ...
Please provide your email address to receive an email when new articles are posted on . A patient’s frailty should be considered when determining fractionation for WHO grade 4 adult-type diffuse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results